mdlinx mdlinx

Oncology - BMT/SCT News & Articles

Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.

On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx
New! >> Find out who is the Smartest Doc in Oncology!

Articles

Latest (4) Full Text Articles (175) Focus on Bone
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

1 Comparable outcome of stem cell transplant versus bortezomib-based consolidation in myeloma patients after major response to induction Hematology, May 24, 2013    Clinical Article

2 Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey Hematology, May 24, 2013    Clinical Article

3 Primary research on unrelated double umbilical cord blood transplantation and implantation kinetics Hematology, May 24, 2013    Clinical Article

4 Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: an analysis from the GVHD working group of the Japan Society for Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation, May 24, 2013    Clinical Article

Prior Articles

5 Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR Bone Marrow Transplantation, May 23, 2013    Clinical Article

6 IL-10 promoter polymorphism associated with decreased risk of aGvHD after stem cell transplantation: a meta-analysis International Journal of Hematology, May 23, 2013    Clinical Article

7 Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia Leukemia and Lymphoma, May 23, 2013    Review Article

8 BAALC and WT1 expression from diagnosis to hematopoietic stem cell transplantation: Consecutive monitoring in adult patients with core-binding factor-positive AML European Journal of Haematology, May 22, 2013    Clinical Article

9 Comparable outcome of stem cell transplant versus bortezomib-based consolidation in myeloma patients after major response to induction Hematology, May 22, 2013    Clinical Article

10 Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT Bone Marrow Transplantation, May 22, 2013    Clinical Article

11 Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT Bone Marrow Transplantation, May 22, 2013    Clinical Article

12 Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Bone Marrow Transplantation, May 22, 2013    Clinical Article

13 Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy Autoimmunity Reviews, May 21, 2013    Review Article

14 Mortality Rates of Human Metapneumovirus and Respiratory Syncytial Virus Lower Respiratory Tract Infections in Hematopoietic Cell Transplant Recipients Biology of Blood and Marrow Transplantation, May 21, 2013    Clinical Article

15 Feasibility of an outpatient HLA haploidentical stem cell transplantation program in children using a reduced-intensity conditioning regimen and CD3-CD19 depletion Hematology, May 17, 2013    Clinical Article

16 Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey Hematology, May 16, 2013    Clinical Article

17 Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants European Journal of Clinical Pharmacology, May 15, 2013    Clinical Article

18 BK viremia precedes hemorrhagic cystitis in children undergoing allogeneic hematopoietic stem cell transplantation Biology of Blood and Marrow Transplantation, May 15, 2013    Clinical Article

19 Prospective qualitative and quantitative non-invasive evaluation of intestinal acute GVHD by contrast-enhanced ultrasound sonography Bone Marrow Transplantation, May 15, 2013    Clinical Article

20 Late mortality after hematopoietic SCT for a childhood malignancy Bone Marrow Transplantation, May 15, 2013    Clinical Article

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2012

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Other Topics in Oncology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close